Pinnacle Financial Group, Inc.’s Seres Therapeutics MCRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1K Buy
+300
New +$1.51K ﹤0.01% 2085

Other funds holding MCRB

Pinnacle Financial Group, Inc.'s MCRB Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in Seres Therapeutics (MCRB) in Q3 2026: 300 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2085 among its holdings.

40 funds tracked by Wall St. Rank hold MCRB as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 300 shares of Seres Therapeutics worth $1K as of Q3 2026.
  • Seres Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • Seres Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #2085 holding.
  • 40 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.